Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Hepatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Hot Flash Severity Predicts Metabolic-Associated Liver Disease
1
Mins
June 2024
Women experiencing hot flashes have been found to be more likely to receive a diagnosis of metabolic dysfunction-associated steatotic liver disease.
Read more
1
Mins
30th March 2015
Endosialin an Integral Cog in the Liver Fibrosis Machine
DISCOVERY of a new molecule on the surface of hepatic stellate cells has broadened knowledge of the underlying mechanisms that cause liver fibrosis…
1
Mins
30th March 2015
Plant Compounds Represent a Budding Option for Non-Alcoholic Fatty Liver Disease (NAFLD) Treatment
Plant compounds represent a budding option for Non-Alcoholic Fatty Liver Disease (NAFLD) treatment. Read the article and find out more
4
Mins
4th February 2015
AbbVie’s VIEKIRAX® (Ombitasvir/Paritaprevir/Ritonavir) and EXVIERA ® (Dasabuvir) Licensed for Use in the UK for the Treatment of Chronic Hepatitis C
MAIDENHEAD, UK, Jan. 19, 2015 – AbbVie’s all-oral, short course (12 weeks for the majority of patients), interferon-free treatments VIEKIRAX®…
1
Mins
12th January 2015
Artificial Liver Leads the Way as New Life-Saver
BIOARTIFICIAL livers could possess the ability to sustain liver failure (LF) patients until their own internal organs can repair themselves or…
1
Mins
6th January 2015
Liver Cancer Menace May Lie in Surrounding Immunity
MACROPHAGES may constitute the next target for liver cancer treatment as the presence of epidermal growth factor receptor (EGFR) in the cells…
1
Mins
6th January 2015
Gene Culprit behind Metabolic Syndrome Revealed
HEALTHY gut microbiota may be the key to tackling metabolic syndrome (MetS); when a particular gene, known as Toll-like receptor 5 (TLR5), is…
2
Mins
25th November 2014
Experts Call for Greater Awareness of Alcohol Related Liver Disease and Liver Cancer
Vienna, 24 November 2014 – United European Gastroenterology (UEG) is supporting the second annual Awareness Week on Alcohol Related Harm (AWARH)
Loading posts...
« Previous
1
…
12
13
14